ANGIODYNAMICS INC (ANGO)

Data as of Jul 31, 2026, from SEC Form 4 filings.

XNASSURGICAL & MEDICAL INSTRUMENTS & APPARATUSNet insider selling (90d)Watch ANGO

See up to 3 months of ANGO. The 7-day demo opens the 1M and 3M ranges and puts ANGO on your watchlist.

Latest ANGO insider trades

Warren Nighan Jr. - Officer
Open-market sale$344K
Jul 30, 2026
Lawrence T. Weiss - Officer
Open-market purchase$118K
Oct 21, 2025
Stephen A. Trowbridge - Officer
Open-market purchase$10K
Oct 13, 2025
James C. Clemmer - Officer
Open-market purchase$112K
Oct 9, 2025
Laura Piccinini - Officer
Option exercise8,047 sh
Jul 22, 2026
Laura Piccinini - Officer
Tax withholding / forfeiture$62K
Jul 22, 2026
Laura Piccinini - Officer
Option exercise28,336 sh
Jul 22, 2026
Warren Nighan Jr. - Officer
Option exercise5,694 sh
Jul 22, 2026

Follow insider buying without reading every filing

We read every Form 4 as it is filed, ANGO's included, and rank the insider purchases worth a look into a daily trading plan.

Free by email: highlights from the previous session's daily trading plan each market morning, plus a Friday roundup of the week's insider buying.

Basic reads each plan from the previous close, before the open. Compare plans or see the daily plan.

ANGO key statistics

Market cap: $464.70M
Average volume: 609.0K
52 week high: $16.29
52 week low: $9.39
Shares outstanding: 42.05M

Filings (90d)

Form 4

Purchases (90d)

Sales (90d)

$344K

Market cap

$464.70M

632 employees

ANGO insider sentiment, last 90 days

How the dollar value of insider trades on Form 4 split between purchases and sales.

0% Buying100% Selling

1 insider sale totaling $344K and no purchases.

Most active ANGO insiders in the last 90 days

About ANGIODYNAMICS INC (ANGO)

AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.

Headquarters: LATHAM, NY
Employees: 632
Listed: 2004
Exchange: XNAS
Sector: Health Care

https://www.angiodynamics.com SEC filings for ANGO on EDGAR

ANGO Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	1	23,370	$344K
Grant or award	17	340,113
Option exercise	10	401,759
Tax withholding / forfeiture	23	119,442

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

ANGO insider transactions (Form 4)

50 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 1 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Jul 30, 2026	Warren Nighan Jr. - Officer	Open-market sale	Common Stock	23,370	$14.72^{footnote F1}	$344K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.65 to $14.80, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of… Full note on SEC EDGAR
Jul 22, 2026	Laura Piccinini - Officer	Option exercise	Common Stock	8,047^{footnote F1}	$0.00	-
Jul 22, 2026	Laura Piccinini - Officer	Tax withholding / forfeiture	Common Stock	4,506^{footnote F2}	$13.82	$62K
Jul 22, 2026	Laura Piccinini - Officer	Option exercise	Performance Right	28,336	$0.00	-
Footnote F1 (shares): This acquisition of 8,047 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023. Footnote F2 (shares): The exempt disposition of 4,506 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.
Jul 22, 2026	Warren Nighan Jr. - Officer	Option exercise	Common Stock	5,694^{footnote F1}	$0.00	-
Jul 22, 2026	Warren Nighan Jr. - Officer	Tax withholding / forfeiture	Common Stock	1,671^{footnote F2}	$13.82	$23K
Jul 22, 2026	Warren Nighan Jr. - Officer	Option exercise	Performance Right	20,052	$0.00	-
Footnote F1 (shares): This acquisition of 5,694 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023. Footnote F2 (shares): The exempt disposition of 1,671 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.
Jul 22, 2026	Stephen A. Trowbridge - Officer	Option exercise	Common Stock	16,296^{footnote F1}	$0.00	-
Jul 22, 2026	Stephen A. Trowbridge - Officer	Tax withholding / forfeiture	Common Stock	8,319^{footnote F2}	$13.82	$115K
Jul 22, 2026	Stephen A. Trowbridge - Officer	Option exercise	Performance Right	57,381	$0.00	-
Footnote F1 (shares): This acquisition of 16,296 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023. Footnote F2 (shares): The exempt disposition of 8,319 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.
Jul 22, 2026	James C. Clemmer - Officer	Option exercise	Common Stock	52,358^{footnote F1}	$0.00	-
Jul 22, 2026	James C. Clemmer - Officer	Tax withholding / forfeiture	Common Stock	26,728^{footnote F2}	$13.82	$369K
Jul 22, 2026	James C. Clemmer - Officer	Option exercise	Performance Right	184,361	$0.00	-
Footnote F1 (shares): This acquisition of 52,358 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023. Footnote F2 (shares): The exempt disposition of 26,728 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.
Jul 22, 2026	Chad Thomas Campbell - Officer	Option exercise	Common Stock	6,466^{footnote F1}	$0.00	-
Jul 22, 2026	Chad Thomas Campbell - Officer	Tax withholding / forfeiture	Common Stock	2,330^{footnote F2}	$13.82	$32K
Jul 22, 2026	Chad Thomas Campbell - Officer	Option exercise	Performance Right	22,768	$0.00	-
Footnote F1 (shares): This acquisition of 6,466 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023. Footnote F2 (shares): The exempt disposition of 2,330 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.
Jul 15, 2026	Jan Stern Reed	Grant or award	Common Stock	11,887^{footnote F1}	$0.00	-
Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR
Jul 15, 2026	Karen A. Licitra	Grant or award	Common Stock	11,887^{footnote F1}	$0.00	-
Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR
Jul 15, 2026	Wesley Johnson	Grant or award	Common Stock	11,887^{footnote F1}	$0.00	-
Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR
Jul 15, 2026	Howard W. Donnelly	Grant or award	Common Stock	11,887^{footnote F1}	$0.00	-
Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR
Jul 15, 2026	Lorinda Burgess	Grant or award	Common Stock	11,887^{footnote F1}	$0.00	-
Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR
Jul 15, 2026	Eileen O'Shea Auen	Grant or award	Common Stock	11,887^{footnote F1}	$0.00	-
Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR
Jul 15, 2026	Michael E. Tarnoff	Grant or award	Common Stock	11,887^{footnote F1}	$0.00	-
Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR
Jul 15, 2026	Stephen A. Trowbridge - Officer	Grant or award	Common Stock	53,257^{footnote F1}	$0.00	-
Jul 15, 2026	Stephen A. Trowbridge - Officer	Grant or award	Performance Right	53,257	$0.00	-
Footnote F1 (shares): The acquisition of 53,257 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 53,257 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR
Jul 15, 2026	Laura Piccinini - Officer	Grant or award	Common Stock	19,860^{footnote F1}	$0.00	-
Jul 15, 2026	Laura Piccinini - Officer	Grant or award	Performance Right	19,860	$0.00	-
Footnote F1 (shares): The acquisition of 19,860 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 19,860 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR
Jul 15, 2026	Warren Nighan Jr. - Officer	Grant or award	Common Stock	17,966^{footnote F1}	$0.00	-
Jul 15, 2026	Warren Nighan Jr. - Officer	Grant or award	Performance Right	17,966	$0.00	-
Footnote F1 (shares): The acquisition of 17,966 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 17,966 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR
Jul 15, 2026	Chad Thomas Campbell - Officer	Grant or award	Common Stock	16,081^{footnote F1}	$0.00	-
Jul 15, 2026	Chad Thomas Campbell - Officer	Grant or award	Performance Right	16,081	$0.00	-
Footnote F1 (shares): The acquisition of 16,081 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 16,081 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR
Jul 15, 2026	Lawrence T. Weiss - Officer	Grant or award	Common Stock	21,288^{footnote F1}	$0.00	-
Jul 15, 2026	Lawrence T. Weiss - Officer	Grant or award	Performance Right	21,288	$0.00	-
Footnote F1 (shares): The acquisition of 21,288 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 21,288 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR
Jul 16, 2026	Lawrence T. Weiss - Officer	Tax withholding / forfeiture	Common Stock	2,267^{footnote F1}	$14.14	$32K
Footnote F1 (shares): The exempt disposition of 2,267 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
Jul 16, 2026	Stephen A. Trowbridge - Officer	Tax withholding / forfeiture	Common Stock	7,840^{footnote F1}	$14.14	$111K
Jul 17, 2026	Stephen A. Trowbridge - Officer	Tax withholding / forfeiture	Common Stock	3,510^{footnote F2}	$13.51	$47K
Jul 20, 2026	Stephen A. Trowbridge - Officer	Tax withholding / forfeiture	Common Stock	717^{footnote F3}	$13.71	$10K
Footnote F1 (shares): The exempt disposition of 7,840 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR Footnote F2 (shares): The exempt disposition of 3,510 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024. Footnote F3 (shares): The exempt disposition of 717 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Jul 16, 2026	Laura Piccinini - Officer	Tax withholding / forfeiture	Common Stock	4,538^{footnote F1}	$14.14	$64K
Jul 17, 2026	Laura Piccinini - Officer	Tax withholding / forfeiture	Common Stock	3,074^{footnote F2}	$13.51	$42K
Jul 20, 2026	Laura Piccinini - Officer	Tax withholding / forfeiture	Common Stock	616^{footnote F3}	$13.71	$8K
Footnote F1 (shares): The exempt disposition of 4,538 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR Footnote F2 (shares): The exempt disposition of 3,074 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024. Footnote F3 (shares): The exempt disposition of 616 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Jul 16, 2026	Warren Nighan Jr. - Officer	Tax withholding / forfeiture	Common Stock	2,153^{footnote F1}	$14.14	$30K
Jul 17, 2026	Warren Nighan Jr. - Officer	Tax withholding / forfeiture	Common Stock	1,373^{footnote F2}	$13.51	$19K
Jul 20, 2026	Warren Nighan Jr. - Officer	Tax withholding / forfeiture	Common Stock	251^{footnote F3}	$13.71	$3K
Footnote F1 (shares): The exempt disposition of 2,153 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR Footnote F2 (shares): The exempt disposition of 1,373 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024. Footnote F3 (shares): The exempt disposition of 251 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Jul 16, 2026	James C. Clemmer - Officer	Tax withholding / forfeiture	Common Stock	18,588^{footnote F1}	$14.14	$263K
Jul 17, 2026	James C. Clemmer - Officer	Tax withholding / forfeiture	Common Stock	10,649^{footnote F2}	$13.51	$144K
Jul 19, 2026	James C. Clemmer - Officer	Tax withholding / forfeiture	Common Stock	11,764^{footnote F3}	$13.51	$159K
Jul 19, 2026	James C. Clemmer - Officer	Tax withholding / forfeiture	Common Stock	487^{footnote F4}	$13.51	$7K
Jul 20, 2026	James C. Clemmer - Officer	Tax withholding / forfeiture	Common Stock	4,223^{footnote F5}	$13.71	$58K
Footnote F1 (shares): The exempt disposition of 18,588 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR Footnote F2 (shares): The exempt disposition of 10,649 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024. Footnote F3 (shares): The exempt disposition of 11,764 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023. Footnote F4 (shares): The exempt disposition of 487 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2024. Footnote F5 (shares): The exempt disposition of 4,223 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Jul 16, 2026	Chad Thomas Campbell - Officer	Tax withholding / forfeiture	Common Stock	2,367^{footnote F1}	$14.14	$33K
Jul 17, 2026	Chad Thomas Campbell - Officer	Tax withholding / forfeiture	Common Stock	1,112^{footnote F2}	$13.51	$15K
Jul 20, 2026	Chad Thomas Campbell - Officer	Tax withholding / forfeiture	Common Stock	359^{footnote F3}	$13.71	$5K
Footnote F1 (shares): The exempt disposition of 2,367 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR Footnote F2 (shares): The exempt disposition of 1,112 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024. Footnote F3 (shares): The exempt disposition of 359 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Oct 21, 2025	Lawrence T. Weiss - Officer	Open-market purchase	Common Stock	10,000	$11.81^{footnote F1}	$118K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.71 to $11.90, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of… Full note on SEC EDGAR
Oct 13, 2025	Stephen A. Trowbridge - Officer	Open-market purchase	Common Stock	890	$11.16	$10K
Oct 9, 2025	James C. Clemmer - Officer	Open-market purchase	Common Stock	10,000	$11.15^{footnote F1}	$112K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.10 to $11.17 inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of… Full note on SEC EDGAR
Jul 19, 2025	Stephen A. Trowbridge - Officer	Tax withholding / forfeiture	Common Stock	2,585	$8.69	$22K
Jul 20, 2025	Stephen A. Trowbridge - Officer	Tax withholding / forfeiture	Common Stock	717	$8.69	$6K
Jul 21, 2025	Stephen A. Trowbridge - Officer	Tax withholding / forfeiture	Common Stock	667	$8.99	$6K
Jul 19, 2025	Laura Piccinini - Officer	Tax withholding / forfeiture	Common Stock	1,983	$8.69	$17K
Jul 20, 2025	Laura Piccinini - Officer	Tax withholding / forfeiture	Common Stock	616	$8.69	$5K
Jul 19, 2025	Warren Nighan Jr. - Officer	Tax withholding / forfeiture	Common Stock	735	$8.69	$6K
Jul 20, 2025	Warren Nighan Jr. - Officer	Tax withholding / forfeiture	Common Stock	251	$8.69	$2K
Jul 21, 2025	Warren Nighan Jr. - Officer	Tax withholding / forfeiture	Common Stock	277	$8.99	$2K

Recent ANGO Form 8-K filings

Read ANGO company news

Oct 8, 2026Item 2.02, 7.01, 9.01

Read the filing on SEC EDGAR

Oct 8, 2026Item 1.01, 5.02, 9.01

Read the filing on SEC EDGAR

Jul 14, 2026Item 2.02, 7.01, 9.01

Read the filing on SEC EDGAR

Apr 23, 2026Item 8.01

Read the filing on SEC EDGAR

Apr 2, 2026Item 2.02, 7.01, 9.01

Read the filing on SEC EDGAR

Recent ANGO Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Jul 30, 2026	-	-	-	-	View on EDGAR

Congress trades in ANGO

All congress trades

Stock trades in ANGO disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.

Member	Type	Traded	Disclosed	Value range	Owner	Days to disclose	Filing
Debbie Wasserman SchultzDemocrat, FL-25	Sale	Oct 20, 2025	Oct 24, 2025	$2,000 to $2,000	Dependent child	4 days	Original filing

House of Representatives Periodic Transaction Reports from 2024. Senate filings are not included yet. The full history of ANGO beside its insider purchases is in the Congress Tracker.

ANGO insider trading FAQ

What is the latest insider trade for ANGO?

ANGIODYNAMICS INC (ANGO) had 24 insider filings in the last 90 days, with the most recent on 2026-07-31. The full record for ANGO runs to 50 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying ANGO stock?

No insider purchases of ANGO were filed in the last 90 days. 7 purchases are on record for this company.

How many insiders are selling ANGO stock?

1 insider sale of ANGO was filed in the last 90 days, totaling $344K.

Where can I see ANGO SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects ANGO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Jul 31, 2026 - Warren Nighan Jr. view on EDGAR
Jul 24, 2026 - Laura Piccinini view on EDGAR
Jul 24, 2026 - Warren Nighan Jr. view on EDGAR
Jul 24, 2026 - Stephen A. Trowbridge view on EDGAR
Jul 24, 2026 - James C. Clemmer view on EDGAR
Jul 24, 2026 - Chad Thomas Campbell view on EDGAR
Jul 23, 2026 - Jan Stern Reed view on EDGAR
Jul 23, 2026 - Karen A. Licitra view on EDGAR
Jul 23, 2026 - Wesley Johnson view on EDGAR
Jul 23, 2026 - Howard W. Donnelly view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where ANGO's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow ANGO with a 7-day demo

ANGO on your watchlist
Every ANGO Form 4 filing on record
Up to 3 months of ANGO price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

23,370

$344K

Grant or award

340,113

Option exercise

401,759

Tax withholding / forfeiture

119,442

Date

Insider

Transaction

Security

Price

Value

Jul 30, 2026

Warren Nighan Jr. - Officer

Open-market sale

Common Stock

23,370

$14.72^{footnote F1}

$344K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.65 to $14.80, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of… Full note on SEC EDGAR

Jul 22, 2026

Laura Piccinini - Officer

Option exercise

Common Stock

8,047^{footnote F1}

$0.00

Jul 22, 2026

Laura Piccinini - Officer

Tax withholding / forfeiture

Common Stock

4,506^{footnote F2}

$13.82

$62K

Jul 22, 2026

Laura Piccinini - Officer

Option exercise

Performance Right

28,336

$0.00

Footnote F1 (shares): This acquisition of 8,047 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023.
Footnote F2 (shares): The exempt disposition of 4,506 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.

Jul 22, 2026

Warren Nighan Jr. - Officer

Option exercise

Common Stock

5,694^{footnote F1}

$0.00

Jul 22, 2026

Warren Nighan Jr. - Officer

Tax withholding / forfeiture

Common Stock

1,671^{footnote F2}

$13.82

$23K

Jul 22, 2026

Warren Nighan Jr. - Officer

Option exercise

Performance Right

20,052

$0.00

Footnote F1 (shares): This acquisition of 5,694 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023.
Footnote F2 (shares): The exempt disposition of 1,671 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.

Jul 22, 2026

Stephen A. Trowbridge - Officer

Option exercise

Common Stock

16,296^{footnote F1}

$0.00

Jul 22, 2026

Stephen A. Trowbridge - Officer

Tax withholding / forfeiture

Common Stock

8,319^{footnote F2}

$13.82

$115K

Jul 22, 2026

Stephen A. Trowbridge - Officer

Option exercise

Performance Right

57,381

$0.00

Footnote F1 (shares): This acquisition of 16,296 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023.
Footnote F2 (shares): The exempt disposition of 8,319 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.

Jul 22, 2026

James C. Clemmer - Officer

Option exercise

Common Stock

52,358^{footnote F1}

$0.00

Jul 22, 2026

James C. Clemmer - Officer

Tax withholding / forfeiture

Common Stock

26,728^{footnote F2}

$13.82

$369K

Jul 22, 2026

James C. Clemmer - Officer

Option exercise

Performance Right

184,361

$0.00

Footnote F1 (shares): This acquisition of 52,358 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023.
Footnote F2 (shares): The exempt disposition of 26,728 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.

Jul 22, 2026

Chad Thomas Campbell - Officer

Option exercise

Common Stock

6,466^{footnote F1}

$0.00

Jul 22, 2026

Chad Thomas Campbell - Officer

Tax withholding / forfeiture

Common Stock

2,330^{footnote F2}

$13.82

$32K

Jul 22, 2026

Chad Thomas Campbell - Officer

Option exercise

Performance Right

22,768

$0.00

Footnote F1 (shares): This acquisition of 6,466 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023.
Footnote F2 (shares): The exempt disposition of 2,330 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.

Jul 15, 2026

Jan Stern Reed

Grant or award

Common Stock

11,887^{footnote F1}

$0.00

Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR

Jul 15, 2026

Karen A. Licitra

Grant or award

Common Stock

11,887^{footnote F1}

$0.00

Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR

Jul 15, 2026

Wesley Johnson

Grant or award

Common Stock

11,887^{footnote F1}

$0.00

Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR

Jul 15, 2026

Howard W. Donnelly

Grant or award

Common Stock

11,887^{footnote F1}

$0.00

Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR

Jul 15, 2026

Lorinda Burgess

Grant or award

Common Stock

11,887^{footnote F1}

$0.00

Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR

Jul 15, 2026

Eileen O'Shea Auen

Grant or award

Common Stock

11,887^{footnote F1}

$0.00

Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR

Jul 15, 2026

Michael E. Tarnoff

Grant or award

Common Stock

11,887^{footnote F1}

$0.00

Footnote F1 (shares): The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of… Full note on SEC EDGAR

Jul 15, 2026

Stephen A. Trowbridge - Officer

Grant or award

Common Stock

53,257^{footnote F1}

$0.00

Jul 15, 2026

Stephen A. Trowbridge - Officer

Grant or award

Performance Right

53,257

$0.00

Footnote F1 (shares): The acquisition of 53,257 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 53,257 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR

Jul 15, 2026

Laura Piccinini - Officer

Grant or award

Common Stock

19,860^{footnote F1}

$0.00

Jul 15, 2026

Laura Piccinini - Officer

Grant or award

Performance Right

19,860

$0.00

Footnote F1 (shares): The acquisition of 19,860 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 19,860 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR

Jul 15, 2026

Warren Nighan Jr. - Officer

Grant or award

Common Stock

17,966^{footnote F1}

$0.00

Jul 15, 2026

Warren Nighan Jr. - Officer

Grant or award

Performance Right

17,966

$0.00

Footnote F1 (shares): The acquisition of 17,966 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 17,966 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR

Jul 15, 2026

Chad Thomas Campbell - Officer

Grant or award

Common Stock

16,081^{footnote F1}

$0.00

Jul 15, 2026

Chad Thomas Campbell - Officer

Grant or award

Performance Right

16,081

$0.00

Footnote F1 (shares): The acquisition of 16,081 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 16,081 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR

Jul 15, 2026

Lawrence T. Weiss - Officer

Grant or award

Common Stock

21,288^{footnote F1}

$0.00

Jul 15, 2026

Lawrence T. Weiss - Officer

Grant or award

Performance Right

21,288

$0.00

Footnote F1 (shares): The acquisition of 21,288 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 21,288 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual… Full note on SEC EDGAR

Jul 16, 2026

Lawrence T. Weiss - Officer

Tax withholding / forfeiture

Common Stock

2,267^{footnote F1}

$14.14

$32K

Footnote F1 (shares): The exempt disposition of 2,267 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.

Jul 16, 2026

Stephen A. Trowbridge - Officer

Tax withholding / forfeiture

Common Stock

7,840^{footnote F1}

$14.14

$111K

Jul 17, 2026

Stephen A. Trowbridge - Officer

Tax withholding / forfeiture

Common Stock

3,510^{footnote F2}

$13.51

$47K

Jul 20, 2026

Stephen A. Trowbridge - Officer

Tax withholding / forfeiture

Common Stock

717^{footnote F3}

$13.71

$10K

Footnote F1 (shares): The exempt disposition of 7,840 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR
Footnote F2 (shares): The exempt disposition of 3,510 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
Footnote F3 (shares): The exempt disposition of 717 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.

Jul 16, 2026

Laura Piccinini - Officer

Tax withholding / forfeiture

Common Stock

4,538^{footnote F1}

$14.14

$64K

Jul 17, 2026

Laura Piccinini - Officer

Tax withholding / forfeiture

Common Stock

3,074^{footnote F2}

$13.51

$42K

Jul 20, 2026

Laura Piccinini - Officer

Tax withholding / forfeiture

Common Stock

616^{footnote F3}

$13.71

$8K

Footnote F1 (shares): The exempt disposition of 4,538 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR
Footnote F2 (shares): The exempt disposition of 3,074 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
Footnote F3 (shares): The exempt disposition of 616 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.

Jul 16, 2026

Warren Nighan Jr. - Officer

Tax withholding / forfeiture

Common Stock

2,153^{footnote F1}

$14.14

$30K

Jul 17, 2026

Warren Nighan Jr. - Officer

Tax withholding / forfeiture

Common Stock

1,373^{footnote F2}

$13.51

$19K

Jul 20, 2026

Warren Nighan Jr. - Officer

Tax withholding / forfeiture

Common Stock

251^{footnote F3}

$13.71

$3K

Footnote F1 (shares): The exempt disposition of 2,153 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR
Footnote F2 (shares): The exempt disposition of 1,373 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
Footnote F3 (shares): The exempt disposition of 251 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.

Jul 16, 2026

James C. Clemmer - Officer

Tax withholding / forfeiture

Common Stock

18,588^{footnote F1}

$14.14

$263K

Jul 17, 2026

James C. Clemmer - Officer

Tax withholding / forfeiture

Common Stock

10,649^{footnote F2}

$13.51

$144K

Jul 19, 2026

James C. Clemmer - Officer

Tax withholding / forfeiture

Common Stock

11,764^{footnote F3}

$13.51

$159K

Jul 19, 2026

James C. Clemmer - Officer

Tax withholding / forfeiture

Common Stock

487^{footnote F4}

$13.51

$7K

Jul 20, 2026

James C. Clemmer - Officer

Tax withholding / forfeiture

Common Stock

4,223^{footnote F5}

$13.71

$58K

Footnote F1 (shares): The exempt disposition of 18,588 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR
Footnote F2 (shares): The exempt disposition of 10,649 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
Footnote F3 (shares): The exempt disposition of 11,764 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023.
Footnote F4 (shares): The exempt disposition of 487 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2024.
Footnote F5 (shares): The exempt disposition of 4,223 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.

Jul 16, 2026

Chad Thomas Campbell - Officer

Tax withholding / forfeiture

Common Stock

2,367^{footnote F1}

$14.14

$33K

Jul 17, 2026

Chad Thomas Campbell - Officer

Tax withholding / forfeiture

Common Stock

1,112^{footnote F2}

$13.51

$15K

Jul 20, 2026

Chad Thomas Campbell - Officer

Tax withholding / forfeiture

Common Stock

359^{footnote F3}

$13.71

$5K

Footnote F1 (shares): The exempt disposition of 2,367 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16… Full note on SEC EDGAR
Footnote F2 (shares): The exempt disposition of 1,112 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
Footnote F3 (shares): The exempt disposition of 359 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.

Oct 21, 2025

Lawrence T. Weiss - Officer

Open-market purchase

Common Stock

10,000

$11.81^{footnote F1}

$118K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.71 to $11.90, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of… Full note on SEC EDGAR

Oct 13, 2025

Stephen A. Trowbridge - Officer

Open-market purchase

Common Stock

890

$11.16

$10K

Oct 9, 2025

James C. Clemmer - Officer

Open-market purchase

Common Stock

10,000

$11.15^{footnote F1}

$112K

Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.10 to $11.17 inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of… Full note on SEC EDGAR

Jul 19, 2025

Stephen A. Trowbridge - Officer

Tax withholding / forfeiture

Common Stock

2,585

$8.69

$22K

Jul 20, 2025

Stephen A. Trowbridge - Officer

Tax withholding / forfeiture

Common Stock

717

$8.69

$6K

Jul 21, 2025

Stephen A. Trowbridge - Officer

Tax withholding / forfeiture

Common Stock

667

$8.99

$6K

Jul 19, 2025

Laura Piccinini - Officer

Tax withholding / forfeiture

Common Stock

1,983

$8.69

$17K

Jul 20, 2025

Laura Piccinini - Officer

Tax withholding / forfeiture

Common Stock

616

$8.69

$5K

Jul 19, 2025

Warren Nighan Jr. - Officer

Tax withholding / forfeiture

Common Stock

735

$8.69

$6K

Jul 20, 2025

Warren Nighan Jr. - Officer

Tax withholding / forfeiture

Common Stock

251

$8.69

$2K

Jul 21, 2025

Warren Nighan Jr. - Officer

Tax withholding / forfeiture

Common Stock

277

$8.99

$2K

Filed

Filer

Relationship

Market value

Notice

Jul 30, 2026

View on EDGAR

Member

Type

Traded

Disclosed

Value range

Owner

Days to disclose

Filing

Debbie Wasserman SchultzDemocrat, FL-25

Sale

Oct 20, 2025

Oct 24, 2025

$2,000 to $2,000

Dependent child

4 days

Original filing